Clinical trials: HIV-1 Infected Adults With Controlled Viremia
HIV-1 Infected Adults With Controlled Viremia
Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial
Background: The Human Immunodeficiency Virus (HIV) attacks the immune system. Scientists have created a gene that could be transferred to the cells of people with HIV.
- Trial name
- VRC 603 (NCT03374202)
- Testing
- VRC-HIVAAV070-00-GT (AAV8-VRC07)
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
HIV-1 Infected Adults With Controlled Viremia
Long Acting Cabotegravir Plus Rilpivirine in People Living With HIV-1 Aged ≥ 60 Years for 24 Months.
People Living with HIV-1 (PLHIV) are an important group of patients attending their specialist's and continue growing thanks to efficacy antiretroviral treatment (ART), allowing them to stabilize the HIV-infection and to live a…
- Trial name
- LOVER60 (NCT06646562)
- Testing
- Cabotegravir LA + Rilpivirine LA
- Where
- 8 sites in Spain
- Volunteers
- 120 people
- Sponsor
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia